A Tutorial for Analysing the Cost-effectiveness of Alternative Methods for Assessing Chemical Toxicology: The Case of Acute Oral Toxicity Prediction by Norlen, H. et al.
Introduction
Acute toxicity refers to adverse effects occurring
from oral or dermal administration of: a) a single
dose of a substance; b) multiple doses given within
24 hours; or c) an inhalation exposure of four hours
(1). Information on acute oral toxicity is a standard
requirement in several regulatory frameworks for,
for example, industrial chemicals (2), biocides (3),
and agrochemicals (4).
The hazard assessment and classification of
chemicals with regard to acute oral toxicity are
based on the acute lethal dose to 50% of the treated
animals (the ‘LD50 value’). Following the Euro -
pean Union’s Regulation on Classification,
Labelling and Packaging (CLP; 5), chemicals are
classified in one of four toxicity categories based on
their LD50 values. The most toxic chemicals, with
LD50 values below 5mg/kg bodyweight, belong to
category 1; values above 5 and below 50mg/kg
bodyweight belong to category 2; values above 50
and below 300mg/kg bodyweight belong to cat egory
3; and values above 300 and below 2,000mg/kg
bodyweight belong to category 4. Chemicals with
LD50 values greater than 2,000mg/kg bodyweight
are not categorised. 
At present, all the accepted methods for deter-
mining acute oral toxicity for regulatory purposes
are based on animal (in vivo) tests. After the clas-
sical median lethal dose (LD50) test (OECD TG
401), which used at least 20 animals per test, was
abolished in 2002, three modified in vivo tests were
approved by the OECD: the ‘Fixed-Dose Procedure
Test’ (FDP; OECD TG 420), the ‘Acute Toxic Class
Method Test’ (ATC; OECD TG 423) and the ‘Up-
and-Down Procedure’ (UDP; OECD TG 425) (6–8).
These tests are sequential tests, where the out-
come of the previous step/dose determines the next
dose to be tested, and the number of animals used
per test can then be considerably reduced (to a
minimum of five animals per test).
Given the strong ethical concerns surrounding
the use of animals in toxicity testing and of relying
on mortality as an endpoint, substantial effort has
been put in the development and validation of
alternative methods that provide reliable informa-
tion about this endpoint without the use of labora-
tory animals. Two major alternatives to standard
in vivo tests for acute oral toxicity are in silico
methods such as Quantitative Structure–Activity
Relationships (QSARs), and in vitro methods such
as cell-based assays, as reviewed by Lapenna et al.
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Summary — Compared with traditional animal methods for toxicity testing, in vitro and in silico methods
are widely considered to permit a more cost-effective assessment of chemicals. However, how to assess the
cost-effectiveness of alternative methods has remained unclear. This paper offers a user-oriented tutorial
for applying cost-effectiveness analysis (CEA) to alternative (non-animal) methods. The purpose is to illus-
trate how CEA facilitates the identification of the alternative method, or the combination of methods, that
offers the highest information gain per unit of cost. We illustrate how information gains and costs of sin-
gle methods and method combinations can be assessed. By using acute oral toxicity as an example, we
apply CEA to a set of four in silico methods (ToxSuite, TOPKAT, TEST, ADMET Predictor), one in vitro method
(the 3T3 Neutral Red Uptake cytotoxicity assay), and various combinations of these methods. Our results
underline that in silico tools are more cost-effective than the in vitro test. Battery combinations of alterna-
tive methods, however, do not necessarily outperform single methods, because additional information
gains from the battery are easily outweighed by additional costs.
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